Abacavir

Product NDC: 0121-0897
11-digit product format: 001210897
Labeler code: 0121
Product ID: 0121-0897_ac38acc1-cc0b-9467-e053-2995a90adf11
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Abacavir
Dosage form: SOLUTION
Route: ORAL
Labeler: Pharmaceutical Associates, Inc.
Application: ANDA201107
Marketing category: ANDA
Marketing start: 2020-08-20
Marketing end: 0000-00-00
Substance: ABACAVIR SULFATE
Active strength: 20 mg/mL
Pharmacologic classes: Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA]
NDC exclude flag: No
Listing certified through: 2021-12-31
Current FDA listing: Historical FDA.report record

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0121-0897-15	ML - Milliliter	0121-0897	a1c8a67a-0605-4f54-8149-77084fee32d7	1	2021-01-08
0121-0897-20	ML - Milliliter	0121-0897	39d741f4-b54d-49cc-8ca3-6683b95b97c8	1	2021-01-08

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
J220T4J9Q2	ABACAVIR SULFATE	188062-50-2	ABACAVIR SULFATE
WR2TIP26VS	ABACAVIR	136470-78-5	Abacavir

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
0121-0897-20	00121089720	10 TRAY in 1 CASE (0121-0897-20) > 10 CUP, UNIT-DOSE in 1 TRAY > 1 mL in 1 CUP, UNIT-DOSE (0121-0897-15)	10 tray	2020-08-20	0000-00-00	No	No	Current